お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
990150

世界の抗肥満薬の市場規模調査:作用機序別(末梢作用薬、中枢作用薬)、薬タイプ別(処方薬、OTC薬)、地域別予測(2020年~2027年)

Global Anti-obesity Drugs Market Size study, by Mechanism of Action (Peripherally Acting Drugs, and Centrally Acting Drugs), by Drug Type (Prescription Drugs, and OTC Drugs)and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
世界の抗肥満薬の市場規模調査:作用機序別(末梢作用薬、中枢作用薬)、薬タイプ別(処方薬、OTC薬)、地域別予測(2020年~2027年)
出版日: 2021年02月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗肥満薬の市場規模は、2019年に約13億9000万米ドルであり、2020年から2027年の予測期間にわたって15%以上の成長率で成長すると予想されています。

抗肥満薬は、食欲を減らすかカロリー摂取量を増やすことで体脂肪を減らすのに役立ちます。世界中の肥満患者の数は、運動不足やファーストフードの消費によって増加すると予測されています。不健康なファーストフードの摂取と可処分所得の増加は、抗肥満治療薬に対する消費者の需要を刺激します。高度な医学調査はまた、製薬企業、医科大学や研究所、政府機関を通じて、抗肥満薬の開発に大きく貢献しています。しかし、高コストは2020年から2027年の予測期間にわたる市場の成長を妨げる可能性があります。また、食生活の変化やファーストフードの消費量の増加は、抗肥満薬の利用と需要につながります。

当レポートでは、抗肥満薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、作用機序別・タイプ別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の抗肥満薬市場の定義と範囲

第3章 世界の抗肥満薬市場力学

  • 抗肥満薬市場の影響分析

第4章 世界の抗肥満薬市場業界分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターの5フォースモデルへの未来的なアプローチ
  • PEST分析
    • 政治
    • 経済的
    • ソーシャル
    • 技術的
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 作用機序別の世界の抗肥満薬市場

  • 市場スナップショット
  • 作用機序別の世界の抗肥満薬市場-潜在的な分析
  • 作用機序別の世界の抗肥満薬市場の推定と予測
  • 抗肥満薬市場:サブセグメント分析
    • 末梢作用薬
    • 中枢作用薬

第6章 薬タイプ別の世界の抗肥満薬市場

  • 市場スナップショット
  • 薬タイプ別の世界の抗肥満薬市場-潜在的な分析
  • 世界の抗肥満薬市場の推定と薬の種類別の予測
  • 抗肥満薬市場:サブセグメント分析
    • 処方薬
    • OTC薬

第7章 世界の抗肥満薬市場:地域別分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Boehringer Ingelheim GmbH
    • Arena Pharmaceuticals Inc.
    • Takeda Pharmaceuticals Company Limited
    • Zydus Cadila
    • Rhythm Pharmaceuticals
    • Merck & Co. Inc.
    • Eisai Co. Ltd.
    • Novo Nordisk A/S
    • Orexigen Therapeutics Inc.
    • GlaxoSmithKline PLC

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Anti-obesity Drugs market, report scope
  • TABLE 2. Global Anti-obesity Drugs market estimates & forecasts by Region 2017-2027 (USDBillion)
  • TABLE 3. Global Anti-obesity Drugs market estimates & forecasts byMechanism of action2017-2027 (USDBillion)
  • TABLE 4. Global Anti-obesity Drugs market estimates & forecasts byDrug type2017-2027 (USDBillion)
  • TABLE 5. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 6. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 7. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 8. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 9. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 10. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 11. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 12. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 13. Global Anti-obesity Drugs market by segment, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 14. Global Anti-obesity Drugs market by region, estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 15. U.S. Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 16. U.S. Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 17. U.S. Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 18. Canada Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 19. Canada Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 20. Canada Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 21. UKAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 22. UKAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 23. UKAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 24. Germany Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 25. Germany Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 26. Germany Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 27. RoEAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 28. RoEAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 29. RoEAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 30. China Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 31. China Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 32. China Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 33. India Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 34. India Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 35. India Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 36. Japan Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 37. Japan Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 38. Japan Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 39. RoAPACAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 40. RoAPACAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 41. RoAPACAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 42. Brazil Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 43. Brazil Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 44. Brazil Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 45. Mexico Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 46. Mexico Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 47. Mexico Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 48. RoLAAnti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 49. RoLAAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 50. RoLAAnti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 51. Row Anti-obesity Drugs market estimates & forecasts, 2017-2027 (USDBillion)
  • TABLE 52. Row Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 53. Row Anti-obesity Drugs market estimates & forecasts by segment 2017-2027 (USDBillion)
  • TABLE 54. List of secondary sources, used in the study of global Anti-obesity Drugs market
  • TABLE 55. List of primary sources, used in the study of global Anti-obesity Drugs market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Anti-obesity Drugs market, research methodology
  • FIG 2. Global Anti-obesity Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Anti-obesity Drugs market, key trends 2019
  • FIG 5. Global Anti-obesity Drugs market, growth prospects 2020-2027
  • FIG 6. Global Anti-obesity Drugs market, porters 5 force model
  • FIG 7. Global Anti-obesity Drugs market, pest analysis
  • FIG 8. Global Anti-obesity Drugs market, value chain analysis
  • FIG 9. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
  • FIG 10. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
  • FIG 11. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
  • FIG 12. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
  • FIG 13. Global Anti-obesity Drugs market by segment, 2017 & 2027 (USDBillion)
  • FIG 14. Global Anti-obesity Drugs market, regional snapshot 2017 & 2027
  • FIG 15. North America Anti-obesity Drugs market2017 & 2027 (USDBillion)
  • FIG 16. Europe Anti-obesity Drugs market2017 & 2027 (USDBillion)
  • FIG 17. Asia pacific Anti-obesity Drugs market2017 & 2027 (USDBillion)
  • FIG 18. Latin America Anti-obesity Drugs market2017 & 2027 (USDBillion)
  • FIG 19. Global Anti-obesity Drugs market, company market share analysis (2019)
目次

Global Anti-obesity Drugs Market is valued approximately USD 1.39 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 15% over the forecast period 2020-2027. Anti-obesity medications help decrease body fat by either decreasing appetite or rising calorie intake. The increases in number of obese patients worldwide are predicted to be exacerbated by the consumption of fast foods coupled with lack of exercise. The intake of unhealthy fast foods, and rising disposable income, fuel consumer demand for anti-obesity therapeutics. Advanced medical research has also contributed significantly to the development of the anti-obesity medicines through drug-producing firms, medical colleges and institutes, and government agencies. For Instance: According to Trust for America's health, In 2020,The U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country's obesity crisis. The national adult obesity rate has increased by 26 percent since 2008. However, high costsimpedes the growth of the market over the forecast period of 2020-2027. Also, changing eating habits and rising consumption of fast foods will lead to the adoption & demand for Anti-Obesity Drugs.

The regional analysis of global Anti-obesity Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increase in the obese population and high healthcare spending. Whereas,Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income and rising population would create lucrative growth prospects for the Anti-obesity Drugs market across Asia-Pacific region.

Major market player included in this report are:

Boehringer Ingelheim GmbH

Arena Pharmaceuticals Inc.

Takeda Pharmaceuticals Company Limited

Zydus Cadila

Rhythm Pharmaceuticals

Merck & Co. Inc.

Eisai Co. Ltd.

Novo Nordisk A/S

Orexigen Therapeutics Inc.

GlaxoSmithKline PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Mechanism of Action:

Peripherally Acting Drugs

Centrally Acting Drugs

By Drug Type:

Prescription Drugs

OTC Drugs

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Anti-obesity Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Anti-obesity Drugs Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Anti-obesity Drugs Market, by Mechanism of action,2018-2027 (USD Billion)
    • 1.2.3. Anti-obesity Drugs Market, by Drug type,2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Anti-obesity Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Anti-obesity Drugs Market Dynamics

  • 3.1. Anti-obesity Drugs Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Anti-obesity Drugs MarketIndustry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Anti-obesity Drugs Market, by Mechanism of action

  • 5.1. Market Snapshot
  • 5.2. Global Anti-obesity Drugs Market by Mechanism of action, Performance - Potential Analysis
  • 5.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Mechanism of action2017-2027 (USD Billion)
  • 5.4. Anti-obesity Drugs Market, Sub Segment Analysis
    • 5.4.1. Peripherally Acting Drugs
    • 5.4.2. Centrally Acting Drugs

Chapter 6. Global Anti-obesity Drugs Market, by Drug type

  • 6.1. Market Snapshot
  • 6.2. Global Anti-obesity Drugs Market by Drug type, Performance - Potential Analysis
  • 6.3. Global Anti-obesity Drugs Market Estimates & Forecasts by Drug type2017-2027 (USD Billion)
  • 6.4. Anti-obesity Drugs Market, Sub Segment Analysis
    • 6.4.1. Prescription Drugs
    • 6.4.2. OTC Drugs

Chapter 7. Global Anti-obesity Drugs Market, Regional Analysis

  • 7.1. Anti-obesity Drugs Market, Regional Market Snapshot
  • 7.2. North America Anti-obesity Drugs Market
    • 7.2.1. U.S.Anti-obesity Drugs Market
      • 7.2.1.1. Mechanism of actionbreakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Drug typebreakdown estimates & forecasts, 2017-2027
    • 7.2.2. CanadaAnti-obesity Drugs Market
  • 7.3. Europe Anti-obesity Drugs Market Snapshot
    • 7.3.1. U.K. Anti-obesity Drugs Market
    • 7.3.2. Germany Anti-obesity Drugs Market
    • 7.3.3. France Anti-obesity Drugs Market
    • 7.3.4. Spain Anti-obesity Drugs Market
    • 7.3.5. Italy Anti-obesity Drugs Market
    • 7.3.6. Rest of EuropeAnti-obesity Drugs Market
  • 7.4. Asia-PacificAnti-obesity Drugs Market Snapshot
    • 7.4.1. China Anti-obesity Drugs Market
    • 7.4.2. India Anti-obesity Drugs Market
    • 7.4.3. JapanAnti-obesity Drugs Market
    • 7.4.4. Australia Anti-obesity Drugs Market
    • 7.4.5. South Korea Anti-obesity Drugs Market
    • 7.4.6. Rest of Asia PacificAnti-obesity Drugs Market
  • 7.5. Latin America Anti-obesity Drugs Market Snapshot
    • 7.5.1. Brazil Anti-obesity Drugs Market
    • 7.5.2. Mexico Anti-obesity Drugs Market
  • 7.6. Rest of The World Anti-obesity Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Boehringer Ingelheim GmbH
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Arena Pharmaceuticals Inc.
    • 8.2.3. Takeda Pharmaceuticals Company Limited
    • 8.2.4. Zydus Cadila
    • 8.2.5. Rhythm Pharmaceuticals
    • 8.2.6. Merck & Co. Inc.
    • 8.2.7. Eisai Co. Ltd.
    • 8.2.8. Novo Nordisk A/S
    • 8.2.9. Orexigen Therapeutics Inc.
    • 8.2.10. GlaxoSmithKline PLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.